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Background. Typical pulmonary carcinoids represent less than 5% of primary lung tumors. In patients with typical bronchial
carcinoid, formal surgical resection still remains the gold-standard treatment. Data regarding long-term outcome in using
ﬂexible bronchoscope-based modalities under conscious sedation is very limited. Objectives.W es o u g h tt oi n v e s t i g a t e ,o v e r
extended follow-up period, the eﬀectiveness of endobronchial resection for carcinoid tumors with curative intent using ﬂexible
bronchoscopy. Methods. Nd:YAG laser photoresection using ﬂexible bronchoscope under conscious sedation. Follow-up included
repeatbronchoscopyevery6monthsandchestCTeveryyear.Results.Tenpatientsaged24to70yearswithendobronchialcarcinoid
were treated. The tumor location was variable: 2 left Main bronchus, 1 left upper lobe bronchus, 2 right main bronchus, 2 right
middle lobe bronchus and 3 right lower lobe bronchus. No major complications were observed. The patients required between 2
and 4 procedures. Patients were followed for a median period of 29 months with no evidence of tumor recurrence. Conclusions.
Endobronchial laser photoresection of typical bronchial carcinoids using ﬂexible bronchsocopy under conscious sedation is an
eﬀective treatment modality for a subgroup of patients that provides excellent long-term results that are similar to outcome
obtained by more invasive procedures.
Copyright © 2009 Leonardo Fuks et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Bronchial carcinoids account for less than 5% of all primary
lung tumors in adults [1]. Roughly 20% of all carcinoid
tumors present as purely intralumonal polyp-like bronchial
lesions without gross roentgenologically detectable involve-
ment of the bronchial wall and lung [1, 2].
The diﬀerentiation of bronchial carcinoid as “typical”
or “Atypical” has a clinical and therapeutic importance [3].
Typical carcinoids have an excellent prognosis with a 10-
year survival rate of more than 90%. In contrast, atypical
carcinoids tend to be more aggressive and metastatic with a
10-year survival rate of less than 60% [4, 5].
Although less aggressive than other bronchogenic
tumors, atypical carcinoids must be treated as malignant
tumors [4]. Surgical resection is the treatment of choice for
bronchial carcinoid; however, in the setting of typical and
localized endobronchial carcinoid, endobronchial broncho-
scopic resection may be considered as an eﬀective and safe
alternative to surgery, but data regarding long-term follow-
up is scant.
We analyzed our single center experience in the last
ten years and retrospectively evaluated the clinical and
bronchoscopic outcome of all patients who underwent
endobronchial resection of carcinoid tumors with curative
intentusingﬂexiblebronchoscopyunderconscioussedation.
2.MaterialsandMethods
We retrospectively analyzed the medical records of all
patients who underwent bronchial resection of typical
endobronchial carcinoid at our institute from January 2001
until January 2009. Institutional review board approval was
obtained, but speciﬁc informed consent was not required
for this retrospective study. Informed consent for each
bronchoscopy was obtained prior to the procedure.2 Diagnostic and Therapeutic Endoscopy
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Figure 1: Typical carcinoid obstructing the medial segment of the right middle lobe bronchus of a 52-year-old male (patient no. 6). Before
(a) and three months (b) following bronchoscopic laser photoresection by ﬂexible bronchoscopy.
(a) (b)
Figure 2: Typical carcinoid in the right main stem bronchus of a 24-year-old female (patient no. 4). Before (a) and six months (b) following
4 sessions of bronchoscopic laser photoresection by ﬂexible bronchoscopy.
Selection criteria included the following: proven typ-
ical carcinoid without additional pathology conﬁrmed by
endobronchial biopsies, strictly endoluminal disease readily
accessible to curative bronchoscopic therapy, absence of
lymph node enlargement based upon standard CT criteria
(<1-cm short axis).
Carcinoid tumors were deﬁned as “strictly endoluminal”
type based upon both CT data (if the tumor was strictly
endoluminal without thickening of the bronchial wall and
absence of nodal enlargement) and on the endobronchial
view[6].Allcarcinoidsweredescribedasbeing intraluminal,
sessile, or pdunculated by the bronchoscopist. The endo-
bronchialtreatmentincludedphotoresectionusingNd-YAG-
laser (30–40W) by ﬂexible bronchoscopy under conscious
sedation (using midazolam 0.04–0.06mg/Kg and alfentanil
0.5–1.0mg). Following resection, the base of the tumor was
treated by low power setting (15–20W) to prevent recur-
rence. If signiﬁcant bleeding occurred during resection a
diluted topical epinephrine (1:20000) application was used.
A rigid bronchoscope was available on the bronchoscopy
suite along with additional safety measures to isolate the
bleeding site such as a balloon tamponade catheter. All
procedures were done on an ambulatory day-care setting.
All patients underwent repeated bronchoscopic exam-
ination at 3, 6, and 12 months after the ﬁrst session.
Biopsies were taken upon each follow-up examination to
ensure that no recurrence had occures. If the tumor persisted
after four bronchoscopic treatment sessions, surgery was
recommended. Biopsies were always taken and one year after
the ﬁrst procedure, patients were referred for follow-up chest
CT.
After the ﬁrst year, we repeated bronchoscopy every 6
months for one more year and then once a year.
3. Results
We treated 10 patients (3 female and 7 males aged 24 to 70
years old) diagnosed with typical endobronchial carcinoid
who were diagnosed as eligible for complete bronchoscopic
resection by laser therapy. There were also 3 patients referred
forpartialresectionpriortosurgerythatwerenotincludedinDiagnostic and Therapeutic Endoscopy 3
Table 1: Demographic and clinical characteristics of study group
patients.
No. Age/gender Location Sessions Follow-up (month)
1 70/f LUL 4 72
2 32/f RLL 2 24
3 30/m RLL 2 12
4 24/f RMSB 4 24
5 35/m RLL 2 12
6 52/m RML 3 12
7 37/m LMSB 4 108
8 36/m LMSB 3 24
9 28/m RML 2 24
10 42/m RMSB 3 20
LUL: left upper lobe; RLL: right lower lobe; RMSB: right main stem.
the analysis (Table 1). Symptoms included cough, hemopty-
sis, and recurrent pneumonia. The tumor was located at var-
ious sites (2 Left Main bronchus, 1 left upper lobe bronchus,
2 right main bronchus, 2 right middle lobe bronchus, and
3 right lower lobe bronchus). The patients required between
2 and 4 procedures to achieve complete eradication of the
tumor that was observed in all patients. No patient who had
been referred for bronchoscopic treatment required surgery.
We followed the patients for a median of 29 months (range
from 12 to 156 months). The follow-up counting starts upon
theﬁrstbronchoscopicexamination. Weplantofollowupall
the patients for a total of 5 years according to this protocol,
since cure is considered to occur following ﬁve years. At
the end of the observation period all patients were free of
disease both endoscopically and by radiographic criteria. No
major complications (such as death, need for mechanical
ventilation, or major bleeding) occurred, and no postlaser
stenosis was observed. Representative ﬁgures of patients no.
4 and no. 6 are given on Figures 1 and 2.
4. Discussion
Bronchial carcinoids are rare malignant neoplasms, account-
ing for 2%–5% of all lung tumors, with an approxi-
mate annual incidence of 2.3–2.8 cases per million of the
population [1, 2]. The classiﬁcation in use (WHO 1999)
makes a distinction between typical and atypical carcinoids.
The Travis-WHO classiﬁcation [3] is as follows: a typical
carcinoid is based upon four elements: a morphological
base, a number of mitoses <2p e r1 0h i g hp o w e rﬁ e l d s
(HPFs),absenceofnecrosis,dimension ≤ 0.5cm;anatypical
carcinoid has the following morphological characteristics:
carcinoid morphology with a number of mitoses ≥2a n d
<10 per 10 HPFs, and areas of coagulative necrosis. In
10%–15% of cases the tumor can present with regional
lymphonodal metastases, and that is why they may be
classiﬁed as malignant neoplasms, even if with a low degree
[3, 4].
Distantmetastasesoccurin15%ofcasesandaretypically
located in the liver, bone, adrenal gland, and brain. At
present, surgery is the gold standard for treatment of this
tumor, with a diﬀerent approach between typical carcinoids,
in which a parenchyma-sparing resection is preferred, and
atypical carcinoids, in which a limited resection should
be obviated [5]. The concept of bronchoscopic treatment
with curative intent for typical bronchial carcinoid has
previously reported [6–10]. The aim of this retrospective
case study was to assess the safety and eﬃcacy of ﬂexible
bronchoscopic ablative therapy for typical endolumonal
bronchial carcinoid.
All studies to date reported high-success rates with good
long-term outcome. A summery of previous reports is given
on Table 2.W ew e r ea b l et od e m o n s t r a t et h a tl a s e rp h o t o -
resection using ﬂexible bronchoscope is a safe and eﬀective
method to treat selected patients with bronchial carcinoids
without the need for general anesthesia on an ambulatory
service basis. It should be stressed that laser was used to
coagulate and vaporize part of the tumor but mechanical
resection of the tumor was followed upon the initial
procedure to ensure a reliable pathological examination. We
showed over a long-term observation period that patients
responded well to bronchoscopic treatment and that their
survival rates were similar to patients treated with rigid-
bronchoscopy ablative techniques [6–10]a n dc o n v e n t i o n a l
surgery [11–13]. Although the use of ﬂexible bronchoscopy
increased the number of sessions as compared with the use
of rigid bronchoscopy that sometimes enables the physician
to complete the procedure in 1-2 sessions.
Strictly, endoluminal typical carcinoids of the lung
appear to be quite amenable to bronchoscopic resection.
They are often centrally located, with low rates of lymph
node invasion and distant metastases [6].
As Cavaliere et al. point out [7], there are two major
requirements for curative laser photo-resection for endo-
bronchial carcinoids. The ﬁrst is that tumor growth is
strictly endoluminal as determined by CT, endoscopy, and
endobronchial ultrasound. The second is that the base would
be small enough and within range of the laser beam. This
is best assessed after resection of the endobronchial tumor.
If good control of the implantation base is achieved, cure is
accomplished consistently.
Although, from an oncologic point of view, surgery is
considered the “gold standard treatment,” bronchoscopic
endobronchial resection has been an accepted strategy in
bronchial carcinoid treatment [11–13].
Parenchyma-sparingresectionisanimportant goalwhen
dealing with endobronchial tumors and must be the ﬁrst
option whenever feasible [13].
The main limitation of the current study is its retro-
spective design and the fact that its conclusions advocating
ﬂexible-bronchoscopy treatment are based on a single-center
experience.
In contrast to a previous recommendation that ﬂexible
bronchoscopy should be used only as an complementary
toolforrigidbronchoscopy-basedtechniques[7],weshowed
thatﬂexiblebronchoscopictherapyunderconscioussedation
may be considered as a tissue-sparing treatment alternative4 Diagnostic and Therapeutic Endoscopy
Table 2: Summery of studies regarding curative bronchoscopic therapy for bronchial carcinoids.
Studies No. of patients Median follow-up (months) Long-term success rate Technique
Sutedja et al. [6] 11 70 55% RB+laser or mechanical under GA
Cavaliere et al. [7] 38 24 92% RB+ laser under GA
Van Boxem et al. [8] 19 29 73% RB+ laser under GA
Luckraz et al. [9] 28 105 94% RB+MR under GA
Bertoletti et al. [10]
18 55 96% RB+ cryotherapy under GA (14 patients)
FB+ cryotherapy (4 patients)
Current study 10 24 100% FB+ laser under CS
RB: rigid bronchoscopy; GA: general anesthesia; MR: mechanical resection; FB: ﬂexible bronchoscopy; CS: conscious sedation.
for rigid bronchoscopy and formal surgery in a selected
group of patients who present an intraluminal, typical
bronchial carcinoid. Usually, more than a single endoscopic
session is required to achieve cure, and patients should be
closely and regularly monitored following the procedure.
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